Assembly of Curli Fibers by Escherichia coli
大肠杆菌组装 Curli 纤维
基本信息
- 批准号:7777796
- 负责人:
- 金额:$ 35.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Amino Acid SequenceAmyloidAmyloid fibersAttenuatedBacteriaBiochemicalBiochemistryBiogenesisBiologicalBiological AssayCell surfaceCellsCrystallizationDataEmployee StrikesEnterobacteriaceaeEscherichia coliFiberGeneticGoalsImmune Cell ActivationImmunofluorescence ImmunologicLipoproteinsLiposomesMapsMeasuresMediatingMembraneMicrobial BiofilmsMicroscopyMinorModelingMolecularOrganellesPathway interactionsPeptidesPositioning AttributeProcessPropertyProtein SubunitsProteinsProtocols documentationResearch PersonnelResolutionSalmonellaSequence HomologyStructureSwellingSystemTechniquesTestingTherapeuticVirulence FactorsWorkamyloid formationamyloidogenesisbasedeletion analysisdesigndirected evolutionhuman diseasein vitro testingin vivoinsightpolymerizationprogramsprotein foldingprotein misfoldingresearch study
项目摘要
DESCRIPTION (provided by applicant): Escherichia coli and Salmonella spp. are a significant cause of human disease. An important virulence factor for these bacteria is curli. Curli are stable proteinacious fibers that contribute to biofilm formation, host colonization, immune activation and cell invasion. Curli also represent a compelling example of a naturally occurring amyloid fiber. Several important human diseases result from proteins that misfold into amyloid fibers. Curli assembly does not result from protein misfolding, but from a dedicated biogenesis pathway, providing a new paradigm for examining amyloidogenesis. Our long-term goal is to elucidate the molecular mechanism of curli biogenesis so that therapeutic protocols can be designed to attenuate their formation. We developed a testable model of curli assembly that suggests the major curli subunit protein CsgA is secreted from the cell as an unstructured protein that subsequently folds into a ?-sheet rich fiber on the cell surface. We hypothesize that the CsgB nucleator protein catalyzes CsgA's initial folding, but then fiber formation proceeds as a self-perpetuating process with the growing fiber tip able to serve as a template for CsgA polymerization. Secretion of CsgA and CsgB to the cell surface is dependent on the outer membrane localized CsgG protein. E. coli provides us a sophisticated genetic and biochemical system to explore the biogenesis of these unique fibers. In Aim 1 the hypothesis that CsgB presents an amyloid-like template to CsgA during nucleation will be tested. In Aim 2 the sequences in CsgA that facilitate its interaction with CsgB and drive its polymerization into an amyloid fiber will be determined. Finally, in Aim 3 we will test the hypothesis that CsgG forms a curli-specific secretion pore in the outer membrane. Collectively, the experiments described within this proposal will reveal the molecular and structural basis for CsgA secretion, nucleation and polymerization into a fiber.
描述(由申请人提供):大肠杆菌和沙门氏菌属。是人类疾病的重要原因。这些细菌的重要毒力因子是卷。卷曲是稳定的蛋白纤维,有助于生物膜形成,宿主定植,免疫激活和细胞侵袭。 Curli还代表了自然存在的淀粉样纤维的引人注目的例子。几种重要的人类疾病是由于蛋白质折叠成淀粉样蛋白纤维的蛋白质而引起的。 Curli组装不是蛋白质错误折叠而导致的,而是由专用的生物发生途径引起的,为检查淀粉样生成提供了新的范式。我们的长期目标是阐明Curli生物发生的分子机制,以便可以设计治疗方案以减轻其形成。我们开发了一种可测试的冰磨组装模型,该模型表明,主要的Curli亚基蛋白CSGA从细胞中分泌为一种非结构化蛋白质,随后将其折叠成细胞表面上的富含? - 呈富含纤维。我们假设CSGB成核蛋白会催化CSGA的初始折叠,但随后纤维形成作为一种自我延伸过程进行,增长的纤维尖端能够充当CSGA聚合的模板。 CSGA和CSGB向细胞表面的分泌取决于外膜局部CSGG蛋白。大肠杆菌为我们提供了一个复杂的遗传和生化系统,以探索这些独特的纤维的生物发生。在AIM 1中,将测试CSGB在成核过程中向CSGA提出类似淀粉样蛋白的模板的假设。在AIM 2中,将确定CSGA中促进其与CSGB相互作用并将其聚合驱动到淀粉样纤维的序列的序列。最后,在AIM 3中,我们将检验以下假设:CSGG在外膜中形成卷curli特定的分泌孔。总的来说,本提案中描述的实验将揭示CSGA分泌,成核和聚合成纤维的分子和结构基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew Richard Chapman其他文献
Matthew Richard Chapman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew Richard Chapman', 18)}}的其他基金
Controlling Bacterial Amyloid Formation and the Influence of Curli Subunits on Pathogenic Alpha-synuclein Aggregation
控制细菌淀粉样蛋白的形成以及 Curli 亚基对致病性 α-突触核蛋白聚集的影响
- 批准号:
9973388 - 财政年份:2016
- 资助金额:
$ 35.24万 - 项目类别:
Controlling Bacterial Amyloid Formation and the Influence of Curli Subunits on Pathogenic Alpha-synuclein Aggregation
控制细菌淀粉样蛋白的形成以及 Curli 亚基对致病性 α-突触核蛋白聚集的影响
- 批准号:
10369667 - 财政年份:2016
- 资助金额:
$ 35.24万 - 项目类别:
Protein and Chemical Modulation of Curli Amyloid Biogenesis
Curli 淀粉样蛋白生物发生的蛋白质和化学调节
- 批准号:
9078907 - 财政年份:2016
- 资助金额:
$ 35.24万 - 项目类别:
Controlling Bacterial Amyloid Formation and the Influence of Curli Subunits on Pathogenic Alpha-synuclein Aggregation
控制细菌淀粉样蛋白的形成以及 Curli 亚基对致病性 α-突触核蛋白聚集的影响
- 批准号:
10586077 - 财政年份:2016
- 资助金额:
$ 35.24万 - 项目类别:
FASEB SRC on Molecular Mechanisms and Physiological Consequences of Protein Aggregation
FASEB SRC 关于蛋白质聚集的分子机制和生理后果
- 批准号:
8910849 - 财政年份:2015
- 资助金额:
$ 35.24万 - 项目类别:
相似国自然基金
桑椹糖肽靶向Cyclophilin D抑制淀粉样蛋白产生和线粒体功能障碍干预阿尔茨海默病的作用机制
- 批准号:82374059
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
阿尔茨海默病中β-淀粉样蛋白在脑血管沉积的机制与干预研究
- 批准号:82371418
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
淀粉样蛋白在仿生物膜界面的寡聚化研究
- 批准号:22375122
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
β淀粉样蛋白聚集体“激活型”近红外荧光碳点的定向构筑及成像检测研究
- 批准号:82373834
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高频太赫兹波对淀粉样蛋白沉积的干预及其在阿尔茨海默病模型中的应用研究
- 批准号:82302349
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the function of a protective protein in a novel in vitro reconstitution system for disaggregation of ubiquitinated amyloid fibrils
阐明保护蛋白在新型体外重构系统中用于解聚泛素化淀粉样蛋白原纤维的功能
- 批准号:
24K10522 - 财政年份:2024
- 资助金额:
$ 35.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
新規amyloid-β抑制因子ILEIの減少に伴うアルツハイマー病リスクと分子制御機構の解析
新型β淀粉样蛋白抑制剂ILEI降低相关阿尔茨海默病风险及分子调控机制分析
- 批准号:
23K06805 - 财政年份:2023
- 资助金额:
$ 35.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Extracting the detrimental effects of amyloid beta oligomer using contextual learning and controlling it with antagonist molecules
使用情境学习提取β淀粉样蛋白寡聚体的有害影响并用拮抗剂分子控制它
- 批准号:
23K06348 - 财政年份:2023
- 资助金额:
$ 35.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 35.24万 - 项目类别:
Development of inhibitors for amyloid peptide aggregation based on peptidomimetics
基于拟肽的淀粉样肽聚集抑制剂的开发
- 批准号:
23K14318 - 财政年份:2023
- 资助金额:
$ 35.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists